SP
SBRA icon

Sarasin & Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Sarasin & Partners’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-549,851
Closed -$8.19M – 92
2022
Q1 		$8.19M Hold
549,851
– – 0.08% 75
2021
Q4 		$7.45M Sell
549,851
-965
-0.2% -$13.7K 0.07% 74
2021
Q3 		$8.11M Buy
550,816
+155,544
+39% +$2.63M 0.08% 72
2021
Q2 		$7.19M Buy
395,272
+102,683
+35% +$1.83M 0.08% 73
2021
Q1 		$5.08M Buy
+292,589
New +$5.15M 0.06% 76

Other funds holding SBRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Sarasin & Partners's SBRA Position: Q2 2022 in Review

Sarasin & Partners sold out of Sabra Healthcare REIT (SBRA) in Q2 2022, closing a stake of 549,851 shares — an estimated $8.19M sold.

Sarasin & Partners first reported a position in SBRA in Q1 2021 and held it in 5 quarters. The position peaked at $8.19M in Q1 2022. 331 funds tracked by Wall St. Rank hold SBRA as of Q2 2022.

  • Sarasin & Partners reported no remaining Sabra Healthcare REIT position as of Q2 2022 after selling out during the quarter.
  • Sarasin & Partners sold 549,851 Sabra Healthcare REIT shares in Q2 2022, an estimated $8.19M.
  • Sarasin & Partners first reported a position in Sabra Healthcare REIT in Q1 2021 and held it in 5 quarters.
  • Sarasin & Partners's Sabra Healthcare REIT position peaked at $8.19M in Q1 2022.
  • 331 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2022.

Based on Sarasin & Partners's 13F filing for Q2 2022, filed 13 Jul 2022.